AI and GLP-1s: An update on the forces reshaping medical marketing
Description
AI and GLP-1s.
As a healthcare reporter, we often get asked: ‘What are the top industry trends that brand and agency leaders are most focused on?’
And that’s our response: AI and GLP-1s.
Luckily for you, this week’s episode provides a taste of both.
Our feature interview this week is an in-person conversation between managing editor Jack O’Brien and Curtis Sparrer, principal and co-founder of Bospar PR.
Curtis flew in from San Francisco to preview the MM+M tracks at Haymarket Media’s second annual AI Deciphered conference on Thursday.
(Please note, last minute tickets are still available!)
For Trends, pharma editor Lecia Bushak and editor-at-large Steve Madden get you up to speed on the week that was in GLP-1-land: from Pfizer muscling out Novo Nordisk for obesity drug developer Metsera, to the White House’s drug pricing deal with Novo and Eli Lilly.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Music: “Deep Reflection” by DP and Triple Scoop Music.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
United States
